What truly sets the MHS portfolio apart is its combination of cutting-edge science and a practical, customer-focused approach. We’re not just delivering products; we’re offering solutions that are easy to navigate and implement. By simplifying the portfolio into clear, species-specific categories and backing every solution with research and technical expertise, we’re helping producers make confident decisions.
Strategic Marketing & Technology Director for MHS
Cargill Animal Nutrition and Health
Cargill Animal Nutrition & Health introduced a comprehensive range of best-in-class micronutrition solutions and services under its new Micronutrition and Health Solutions (MHS) brand portfolio at EuroTier 2024, November 12-15 in Hannover, Germany.
Dr. Christos Antipatis, the Global Micronutrition & Health Solutions (MHS) Director for Cargill Animal Nutrition & Health, states that the MHS portfolio, which represents a holistic approach integrating precision nutrition and innovative technologies to support animal health, welfare and performance, is designed to address the biggest challenges in the livestock industry.
“Our commitment to our customer is a worldclass science-based portfolio to address customer needs, and advance innovations to solve the industry’s most pressing challenges,” says Antipatis and elaborates.
Cargill’s new Micronutrition and Health Solutions (MHS) portfolio provides a transformative approach to animal nutrition. Could you start by sharing the broader industry challenges Cargill aims to address with this launch?
Today’s livestock industry faces multifaceted and sometimes conflicting challenges—from rising feed costs and fluctuating ingredient quality to consumer demands for antibiotic-free products in the context of increased animal disease outbreaks and a need for environmental sustainability while preserving productivity and profitability for producers. As we confront these pressures, it’s crucial to support animal productivity, meet evolving regulatory standards, and focus on sustainability. Micronutrition and Health Solutions (MHS), a Cargill Animal Nutrition and Health business, has a portfolio designed to tackle these challenges head-on through a holistic approach, integrating precision nutrition and innovative technologies to support animal health, welfare, and performance.
Cargill has placed a strong emphasis on holistic, science-based solutions. Can you explain the guiding principles behind this new portfolio and how they address specific animal health needs?
At its core, our MHS portfolio is centered around the species we serve and also around some specific technology brands such as anti-mycotoxin agents and enzymes. Under them, we structured our product portfolio and our targeted solutions across a range of species and life stages to help producers optimize productivity, safeguard animal health, and minimize environmental impact. By integrating technologies such as postbiotics, phytogenics, anti-mycotoxin agents, and advanced enzyme formulations, we help the many elements in an animal’s diet works synergistically to support health and nutrient efficiency. We’re not just addressing isolated issues but enhancing the entire nutrition ecosystem to support animal wellness and resilience. For example, our Enzae™ enzymes and Notox™ anti-mycotoxin agents help combat the challenges of feed quality, safety, and efficiency, which are essential for both animal health and producer profitability. Our team of experts have designed these solutions with a ‘customer-back’ approach, focusing on solving the real-world problems our customers face daily.
Could you provide some insights into how Cargill is adapting this portfolio for different species and the unique demands they bring?
One of the defining features of the MHS portfolio is its species-specific focus. We’ve streamlined our offerings into eight dedicated product brands to make them clear and accessible for producers. Here are some highlights:
• Ruminants: Diamond V™ – Advanced solutions that support ruminant health, sustainable production, and help producers optimize performance.
• Poultry: Biostrong™ – Proven solutions for poultry performance through enhanced digestion and immune support.
• Swine: Cinergy™ – Holistic solutions in swine at every life stage – designed to support health, performance, and sustainable production.
• Aqua: Syrena™ – Innovative solutions in aqua that contribute to health, performance, profitability, and sustainable production.
• Enzymes: Enzae™ – A versatile portfolio of enzyme solutions designed to meet the nutritional needs of animals – across various diets.
• Anti-Mycotoxin Agents: Notox™ – A complete suite of mycotoxin management solutions – from swift detection to precise application.
Our commitment to our customer is a worldclass science-based portfolio to address customer needs, and advance innovations to solve the industry’s most pressing challenges.
Consumer interest in gut health and immune support is growing. How has this trend influenced the MHS portfolio?
Consumer awareness of gut health and immunity—both for themselves and the animals they care for—has reshaped animal nutrition. This trend has been particularly influential in our focus on postbiotics and phytogenics, which are key components of the MHS portfolio.
Postbiotics, for example, support gut health by supporting the immune system and improving nutrient absorption. These natural, science-backed antibiotic-free solutions help producers optimize animal performance.
This trend not only affects livestock but also pets, as pet owners look for the same health benefits for their companions. Through our brands like TruPet™ and TrueEquine™, we’re offering targeted solutions for cats, dogs, and horses that support gut health, immune function, and overall vitality. Our team has invested heavily in research to ensure that each solution in the MHS portfolio meets both the high expectations of consumers, and the performance needs of producers.
What advice would you give customers looking to integrate these solutions into their operations?
We work with customers to understand and clarify their unique needs and challenges, then identify which MHS solutions align best with those requirements. Our complete offering goes beyond feed additives and incorporates the knowledge and know how we have in nutrition and the use of tools and digital solutions. We encourage customers to consider the entire lifecycle needs of their animals when evaluating our offerings, as each solution is designed to support specific life stages.
What sets the MHS portfolio apart in an increasingly competitive market?
Innovation is at the heart of everything we do. What truly sets the MHS portfolio apart is its combination of cutting-edge science and a practical, customer-focused approach. We’re not just delivering products; we’re offering solutions that are easy to navigate and implement.
By simplifying the portfolio into clear, species-specific categories and backing every solution with research and technical expertise, we’re helping producers make confident decisions. This clarity, paired with our commitment to sustainability and performance, positions the MHS portfolio as a leader in driving meaningful change across the livestock industry.
Where can customers learn more about Cargill’s new MHS portfolio?
During EuroTier 2024, Cargill introduced its new Micronutrition and Health Solutions (MHS) brand portfolio, along with species-specific solutions, on November 12-15 in Hannover, Germany.
Customers can also find extensive information on our MHS website, where we delve into the science behind our portfolio and outline solutions for each species. Additionally, our regional experts and sales representatives are available to provide tailored insights and support. We encourage producers to reach out for a personalized consultation to discover how the MHS portfolio can support their goals for animal health, productivity, and sustainability.
About Dr. Christos Antipatis
Christos Antipatis is the Global Micronutrition & Health Solutions (MHS) Director for Cargill Animal Nutrition & Health, where he is responsible for managing and advancing the MHS portfolio leading the innovation pipeline and seeking new partnerships that strengthen our portfolio.
Christos Antipatis joined Cargill in 2016 as Global Technology Director and since then, has held various global strategic marketing and technology roles. Before joining Cargill, he worked at DSM Nutritional Products for 15 years, holding various global and regional roles in marketing, innovation and other business/technical positions.
Antipatis has an undergraduate degree in agricultural engineering with specialization in animal science from the Agricultural University of Athens in Greece. He earned a Master of Science in Animal Nutrition and, subsequently, a Doctor of Philosophy (PhD) in Nutrition and Reproduction from the University of Aberdeen, UK. In addition, he spent three years doing nutrition-related scientific research at the Rowett Research Institute.
Christos Antipatis lives with his wife, son and daughter in Edinburgh, Scotland. He enjoys walking, exercising, reading, and travelling, particularly back to his home country Greece. He is a wine and whisky enthusiast and has developed a passion for watching rugby.
